72 results on '"Rubio, Jose M."'
Search Results
2. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case–control study in Finland
3. Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies
4. Replication of a neuroimaging biomarker for striatal dysfunction in psychosis
5. What is the duration of untreated psychosis worldwide? – A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies
6. Explainable activity recognition for the elderly
7. A Functional Connectome-Based Neural Signature for Individualized Prediction of Antipsychotic Response in First-Episode Psychosis
8. Edge Artificial Intelligence for real-time automatic quantification of filariasis in mobile microscopy
9. Effects of phase encoding direction on test-retest reliability of human functional connectome
10. Replication of a neuroimaging biomarker for striatal dysfunction in psychosis
11. Diagnostic performance of loop-mediated isothermal amplification (LAMP) and Ultra-sensitive PCR in diagnosis of malaria in western Saudi Arabia
12. Candidate biomarkers in psychiatric disorders: state of the field
13. Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia
14. Effects of phase encoding direction on test-retest reliability of human functional connectome
15. Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia
16. Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database
17. The place of long-acting injectable antipsychotics in the treatment of schizophrenia
18. Digital Technology in Psychiatry: Survey Study of Clinicians
19. Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence
20. An Approach for Selecting the Most Explanatory Features for Facial Expression Recognition
21. The pharmacological treatment of schizophrenia: How far have we come?
22. Striatal functional connectivity in psychosis relapse: A hypothesis generating study
23. Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis
24. Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?
25. How to Make an Effective Offer of Clozapine
26. Digital Technology In Psychiatry: Expectations, Barriers And Understanding Of Clinicians (Preprint)
27. A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome
28. Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data
29. Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study
30. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
31. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort
32. Using Claims Data to Assess Treatment Quality of First-Episode Psychosis
33. Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia
34. Long-Term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study
35. KASP: a genotyping method to rapid identification of resistance in Plasmodium falciparum
36. Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics
37. Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia
38. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis
39. The effects of lorazepam on cortico-striatal connectivity in schizophrenia
40. KASP: a genotyping method to rapid identification of resistance in Plasmodium falciparum
41. Striatal functional connectivity in psychosis relapse: A comparison between antipsychotic adherent and non-adherent patients at the time of relapse
42. Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review
43. Psychosis Relapse During Long-Acting Injectable Antipsychotic Treatment: An Individual Participant Data Meta-Analysis of 19 Trials and 5,111 Individuals with Schizophrenia-Spectrum Disorders
44. Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study
45. Clozapine and long-acting injectable antipsychotics reduce hospitalisation and treatment failure risk in patients with schizophrenia
46. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
47. Comparing Local Search Algorithms for the Beam Angles Selection in Radiotherapy
48. Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
49. Pulmonary vasculature in dogs assessed by three-dimensional fractal analysis and chemometrics
50. Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.